Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™

PHASE4CompletedINTERVENTIONAL
Enrollment

3,054

Participants

Timeline

Start Date

October 5, 2006

Primary Completion Date

June 20, 2007

Study Completion Date

June 20, 2007

Conditions
Influenza
Interventions
BIOLOGICAL

Fluarix™

Trial Locations (37)

10117

GSK Investigational Site, Berlin

10717

GSK Investigational Site, Berlin

13031

GSK Investigational Site, Camillus

13359

GSK Investigational Site, Berlin

14469

GSK Investigational Site, Potsdam

15241

GSK Investigational Site, Pittsburgh

22143

GSK Investigational Site, Hamburg

22335

GSK Investigational Site, Hamburg

22415

GSK Investigational Site, Hamburg

22525

GSK Investigational Site, Hamburg

23507

GSK Investigational Site, Norfolk

27612

GSK Investigational Site, Raleigh

33024

GSK Investigational Site, Pembroke Pines

33484

GSK Investigational Site, Delray Beach

36608

GSK Investigational Site, Mobile

39112

GSK Investigational Site, Magdeburg

45359

GSK Investigational Site, Essen

55131

GSK Investigational Site, Mainz

55624

GSK Investigational Site, Rhaunen

58455

GSK Investigational Site, Witten

60596

GSK Investigational Site, Frankfurt am Main

69469

GSK Investigational Site, Weinheim

73635

GSK Investigational Site, Rudersberg

74363

GSK Investigational Site, Güglingen

89104

GSK Investigational Site, Las Vegas

08244

GSK Investigational Site, Somers Point

01067

GSK Investigational Site, Dresden

04109

GSK Investigational Site, Leipzg

04103

GSK Investigational Site, Leipzig

04229

GSK Investigational Site, Leipzig

3584 CX

GSK Investigational Site, Utrecht

39-200

GSK Investigational Site, Dębica

31-305

GSK Investigational Site, Krakow

39-300

GSK Investigational Site, Mielec

Unknown

GSK Investigational Site, Porąbka

41-103

GSK Investigational Site, Siemianowice Śląskie

50-088

GSK Investigational Site, Wroclaw

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY